Value of routine microbial investigation in low-risk patients with community-acquired pneumonia (CAP)

S. Putinati, L. Ballerin, M. Piattella, L. Ritrovato, A. Potena (Italy)

Source: Annual Congress 2002 - Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Putinati, L. Ballerin, M. Piattella, L. Ritrovato, A. Potena (Italy). Value of routine microbial investigation in low-risk patients with community-acquired pneumonia (CAP). Eur Respir J 2002; 20: Suppl. 38, 2677

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Applicability of Fine criteria in patients hospitalized for community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 67s
Year: 2005

The assessment of prognostic rules in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003

Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011


Etiology of community-acquired pneumonia (CAP) in young hospital patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Are there radiographic differences between patients with community-acquired (CAP) and healthcare-associated pneumonias (HCAP)?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Bacteriological diagnosis in hospitalized community-acquired pneumonia (HCAP): an eighteen-month study
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001

Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Decision making tool in the management of patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2004; 24: Suppl. 48, 538s
Year: 2004

Differential characteristics in elderly patients with community-acquired pneumonia (CAP) who required admission to ICU
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Comparative analysis of clinical and epidemiological characteristics of patients with CAP (community-acquired pneumonia) treated as inpatients and outpatients
Source: Eur Respir J 2006; 28: Suppl. 50, 3s
Year: 2006

Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
Source: ERJ Open Res, 4 (4) 00096-2018; 10.1183/23120541.00096-2018
Year: 2018



Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Clinical stability in patients with community- acquired pneumonia (CAP)
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011

Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003

The impact of empiric antibacterial therapy on mortality for patients hospitalized with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 733s
Year: 2006

Japanese guidelines for the management of community-acquired pneumonia: differential diagnosis of atypical pneumonia and bacterial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006

Criteria for clinical stability in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2013; 42: 742-749
Year: 2013



Biomarkers in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012